uniam Raises ¥770M Series A for Cat Health Longevity

uniam, a Japanese company dedicated to enhancing feline longevity through scientifically-backed nutrition and care, has successfully closed a substantial Series A funding round totaling approximately ¥770 million. This significant capital infusion is set to accelerate the company's ambitious research and development initiatives, particularly its focus on extending the healthy lifespan of cats.

The funding round saw strong backing from prominent investors, with WPower Fund taking the lead. Additional support came from ANOBAKA, Crest Skill Partners, and a group of individual investors. Complementing the equity financing, uniam also secured crucial debt financing from financial institutions including Japan Finance Corporation, Mizuho Bank, Hokuriku Bank, and Shoko Chukin Bank, underscoring a robust financial strategy.

Launched in February 2023, uniam has rapidly established itself by offering a range of over 30 veterinary-supervised food and care products. The company's commitment to evidence-based solutions has resonated with consumers, evidenced by its distribution across premium retail outlets and a network of 190 Aeon Pet stores nationwide. This broad reach has reportedly contributed to an impressive 100-fold increase in monthly sales since its inception, highlighting strong market traction in the premium pet care segment.

A key differentiator for uniam is its data-driven approach to product innovation. The company actively collects and analyzes feline dietary intake data, fostering collaborations with academic institutions and industry partners. This rigorous methodology allows for continuous product refinement and the development of highly targeted health solutions. The company is also advancing joint development projects with major pet insurance provider Anicom, further integrating its offerings into the broader pet health ecosystem.

Looking ahead, uniam is making a significant investment in foundational research. The company plans to inaugurate the “uniam Longevity Lab” in March 2026, a dedicated research institution. Early-stage collaborative research is already underway with Miyagi University and the Graduate School of Agricultural Science at Tohoku University. These partnerships focus on critical areas such as gut health, metabolism, and aging markers, with the explicit goal of translating these scientific insights directly into next-generation food development. The long-term vision even extends to exploring drug discovery avenues.

The newly acquired capital will be strategically deployed across several key areas. Significant portions will fuel marketing efforts and business development to expand market penetration. Investment will also bolster recruitment for its research and development teams, as well as its wholesale sales division. Furthermore, the funds will support ongoing product development, particularly those stemming from academic collaborations, and facilitate the expansion of its wholesale distribution network. This comprehensive funding strategy aims to propel uniam's long-term R&D objectives and accelerate its overall business expansion within the rapidly growing global pet wellness market, which is increasingly prioritizing science-backed solutions.